Keith S. Bahjat

Designer vaccine nanodiscs for personalized cancer immunotherapy

Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat et al. · Nature Materials · 2016 · 1.1K citations

Life Sciences, Immunology, Oncology +13

VISTA is an acidic pH-selective ligand for PSGL-1

Robert J. Johnston, Linhui Julie Su, Jason Pinckney et al. · Nature · 2019 · 392 citations

Life Sciences, Chemistry, Molecular Biology +9

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy

Kristina H. Young, Jason R. Baird, Talicia Savage et al. · PLoS ONE · 2016 · 315 citations · Full text

Medicine, Oncology, Radiation Oncology +17

<i>Listeria</i> -based cancer vaccines that segregate immunogenicity from toxicity

Dirk G. Brockstedt, Martin Giedlin, Meredith L. Leong et al. · Proceedings of the National Academy of Sciences · 2004 · 301 citations · Full text

Life Sciences, Immunology, Microbiology +17

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

Yuri N. Naumov, Keith S. Bahjat, Rudolph Gausling et al. · Proceedings of the National Academy of Sciences · 2001 · 294 citations · Full text

Life Sciences, Endocrinology, Immunology +14